SWAGÊÓƵ

• Doctor of Pharmacy (PharmD) – Western University of Health Sciences (2021)
• Bachelor of Science in Biological Sciences – University of California, Riverside (2012)

• PGY-1 Pharmacy Practice Residency – VA Greater Los Angeles (2022)
• Teaching Certificate – University of Southern California (2022)

Advanced Practice Pharmacist (APh), 2023

Quality improvement, specifically related to appropriate use and implementation of medications in clinical practice.

• California Society of Health-System Pharmacists (CSHP)
• American Pharmacists Association – Academy of Student Pharmacists (APhA-ASP)
• Phi Lambda Sigma Pharmacy Leadership Society – Gamma Nu Chapter
• Rho Chi Society – Gamma Sigma Chapter

• Ton IT, Moon J, Sengul A, Mody FV, Rahman T, Han J, Jackevicius CA. Evidence-based cardiovascular disease medicines' availability in low-cost generic drug programs in the United States. Ann Intern Med 2023; doi:10.7326/M23-0287.
• Sengul A, Escobar E, Jackevicius C. Evidence-based Appraisal of the DAPA-HF Trial. Journal of Contemporary Pharmacy Practice 2020;67(3):24–28. doi: https://doi.org/10.37901/jcphp20-00011
• Sengul A, Santisuk R, Xing W, Kesavan C. Systemic administration of an antagomir designed to inhibit miR-92, a regulator of angiogenesis, failed to modulate skeletal anabolic response to mechanical loading. Physiol Res. 2013;62(2):221-226. doi:10.33549/physiolres.932410
• Sengul A, Mohan S, Kesavan C. Bone response to loading in mice with targeted disruption of the cartilage oligomeric matrix protein gene. Physiol Res. 2012;61(6):637-641. doi:10.33549/physiolres.93230